Updated meta-analysis on the efficacy of genotype-guided antiplatelet therapy versus standard therapy for patients undergoing PCI-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Updated meta-analysis on the efficacy of genotype-guided antiplatelet therapy versus standard therapy for patients undergoing PCI

Published:2020-12 Issue: Volume:196 Page:398-399
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Sahashi Yuki,Kuno Toshiki^ORCID,Bangalore Sripal

Publisher

Elsevier BV

Subject

Hematology

Reference8 articles.

1. Genotype-guided antiplatelet therapy compared with standard therapy for patients with acute coronary syndromes or undergoing percutaneous coronary intervention: a systematic review and meta-analysis;Wang;Thromb. Res.,2020

2. Updated expert consensus statement on platelet function and genetic testing for guiding P2Y12 receptor inhibitor treatment in percutaneous coronary intervention;Sibbing;JACC Cardiovasc. Interv.,2019

3. Effect of genotype-guided oral P2Y12 inhibitor selection vs conventional clopidogrel therapy on ischemic outcomes after percutaneous coronary intervention: the TAILOR-PCI randomized clinical trial;Pereira;JAMA,2020

4. A genotype-guided strategy for oral P2Y12 inhibitors in primary PCI;Claassens;N. Engl. J. Med.,2019

5. Pharmacogenomic approach to selecting antiplatelet therapy in patients with acute coronary syndromes: The PHARMCLO Trial;Notarangelo;J. Am. Coll. Cardiol.,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3